United States (USA) (US)

The genus Holaspis (Squamata: Lacertidae) in Angola: a tale of forgotten specimens and disappearing forests, with the description of a new species (2025) Parrinha D, Marques MP, Gonçalves FMP, Tiutenko A, Bauer AM, Ceríaco LM Journal article, Original article HIV viremic non-progressors: More clues and more questions (2025) Hitschfel J, Walker BD Journal article Microsurgical versus complex physical decongestive therapy for chronic breast cancer-related lymphoedema (2025) Haas Y, Williams OP, Masia J, Pons G, Taylor EM, Katapodi MC, Staub D, et al. Journal article Dynamics of molecular heterogeneity in high-risk luminal breast cancer—From intrinsic to adaptive subtyping (2025) Denkert C, Rachakonda S, Karn T, Weber K, Martin M, Marmé F, Untch M, et al. Journal article Crash testing machine learning force fields for molecules, materials, and interfaces: model analysis in the TEA Challenge 2023 (2025) Poltavsky I, Charkin-Gorbulin A, Puleva M, Fonseca G, Batatia I, Browning NJ, Chmiela S, et al. Journal article White paper and roadmap for quantum gravity phenomenology in the multi-messenger era (2025) Alves Batista R, Amelino-Camelia G, Boncioli D, Carmona JM, di Matteo A, Gubitosi G, Lobo I, et al. Journal article, Review article Nodular fasciitis: a case series unveiling novel and rare gene fusions, including two cases with aggressive clinical behavior (2025) Saoud C, Agaimy A, Stöhr R, Michal M, Wang SKW, Mandavilli S, Charville GW, Linos K Journal article Ancient frameworks as modern templates: exploring reef rubble consolidation in an ancient reef system (2025) Godbold A, James CC, Kießling W, Hohmann N, Jarochowska E, Corsetti FA, Bottjer DJ Journal article Crash testing machine learning force fields for molecules, materials, and interfaces: molecular dynamics in the TEA challenge 2023 (2025) Poltavsky I, Puleva M, Charkin-Gorbulin A, Fonseca G, Batatia I, Browning NJ, Chmiela S, et al. Journal article A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial (2025) Hortobagyi GN, Lacko A, Sohn J, Cruz F, Ruiz Borrego M, Manikhas A, Hee Park Y, et al. Journal article